Login / Signup
Juliette Moyersoen
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 4
Top Topics
Early Onset
Clinical Trial
Respiratory Syncytial Virus
Risk Factors
Top Venues
Infectious diseases and therapy
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Charles Nuttens
,
Juliette Moyersoen
,
Daniel Curcio
,
Zuleika Aponte-Torres
,
Marc Baay
,
Hilde Vroling
,
Bradford D Gessner
,
Elizabeth Begier
Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive Measures.
Infectious diseases and therapy
13 (8) (2024)
Charles Nuttens
,
Juliette Moyersoen
,
Daniel Curcio
,
Zuleika Aponte-Torres
,
Marc Baay
,
Hilde Vroling
,
Bradford D Gessner
,
Elizabeth Begier
Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive Measures.
Infectious diseases and therapy
13 (8) (2024)
Charles Nuttens
,
Juliette Moyersoen
,
Daniel Curcio
,
Zuleika Aponte-Torres
,
Marc Baay
,
Hilde Vroling
,
Bradford D Gessner
,
Elizabeth Begier
Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive Measures.
Infectious diseases and therapy
(2024)
Charles Nuttens
,
Juliette Moyersoen
,
Daniel Curcio
,
Zuleika Aponte-Torres
,
Marc Baay
,
Hilde Vroling
,
Bradford D Gessner
,
Elizabeth Begier
Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive Measures.
Infectious diseases and therapy
13 (8) (2024)